|
[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Miller, K.D., Nogueira, L., Mariotto, A.B., et al. (2019) Cancer Treatment and Survivorship Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 363-385. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Safiyeva, A.K. and Bayramov, N.Y. (2019) The Importance of Colonoscopy in the Treatment of Colorectal Polyps and Colorectal Cancer Screening. Annali Italiani di Chirurgia, 90, 311-317.
|
|
[4]
|
Han, M.A., Zeraatkar, D., Guyatt, G.H., Vernooij, R.W.M., El Dib, R., Zhang, Y., Algarni, A., Leung, G., Storman, D., Valli, C., Rabassa, M., Rehman, N., Parvizian, M.K., Zworth, M., Bartoszko, J.J., Lopes, L.C., Sit, D., Bala, M.M., Alonso-Coello, P. and Johnston, B.C. (2019) Reduction of Red and Processed Meat Intake and Cancer Mortality and Incidence: A Systematic Review and Meta-Analysis of Cohort Studies. Annals of Internal Medicine, 171, 711-720. [Google Scholar] [CrossRef]
|
|
[5]
|
Keum, N. and Giovannucci, E. (2019) Global Burden of Colorectal Cancer: Emerging Trends, Risk Factors and Prevention Strategies. Nature Reviews Gastroenterology & Hepatology, 16, 713-732. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Strum, W.B. (2016) Colorectal Adenomas. The New England Journal of Medicine, 374, 1065-1075. [Google Scholar] [CrossRef]
|
|
[7]
|
Fang, Z., He, M. and Song, M. (2021) Serum Lipid Profiles and Risk of Colorectal Cancer: A Prospective Cohort Study in the UK Biobank. British Journal of Cancer, 124, 663-670. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Tian, Y., Wang, K., Li, J., et al. (2015) The Association between Serum Lipids and Colorectal Neoplasm: A Systemic Review and Meta-Analysis. Public Health Nutrition, 18, 3355-3370. [Google Scholar] [CrossRef]
|
|
[9]
|
Liu, B., Wen, P., Gu, X., et al. (2020) Elevated Serum Triglyceride Predicts Recurrence of Colorectal Polyps in Patients with Advanced Adenomas. Lipids in Health and Disease, 19, 211. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Serafim, P.V.P., Figueiredo, A.G., Felipe, A.V., et al. (2019) Study of Lipid Biomarkers of Patients with Polyps and Colorectal Câncer. Arquivos de Gastroenterologia, 56, 399-404. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Bestard-Escalas, J., Reigada, R., Reyes, J., et al. (2021) Fatty Acid Unsaturation Degree of Plasma Exosomes in Colorectal Cancer Patients: A Promising Biomarker. International Journal of Molecular Sciences, 22, 5060. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
冯越, 邢丽楠, 王棹, 等. NLR与肿瘤同步放化疗预后的相关性研究[J]. 实用肿瘤学杂志, 2019, 33(3): 284-288.
|
|
[13]
|
Loi, S., Sirtaine, N., Piette, F., et al. (2013) Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin with Doxorubicin-Based Chemotherapy: BIG 02-98. Clinical Oncology, 31, 860-867. [Google Scholar] [CrossRef]
|
|
[14]
|
侯智俐, 袁维堂, 孙振强, 等. 术前中性粒细胞与淋巴细胞计数比值对469例结直肠腺癌患者预后影响[J]. 中华肿瘤防治杂志, 2019, 26(9): 643-646. [Google Scholar] [CrossRef]
|
|
[15]
|
刘乐乐, 李华. 中性粒细胞和淋巴细胞VCS参数与NLR对肿瘤患者化疗后细菌感染辅助诊断价值[J]. 中华肿瘤防治杂志, 2019, 26(3): 190-193. [Google Scholar] [CrossRef]
|
|
[16]
|
Templeton, A.J., McNamara, M.G., Seruga, B., et al. (2014) Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. Journal of the National Cancer Institute, 106, dju124. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
吕智豪, 刘华熙, 郭昌, 等. 联合检测肿瘤标志物与炎症指标对结直肠癌的诊断价值[J]. 中国现代医学杂志, 2020, 30(1): 56-62.
|
|
[18]
|
Dimitriou, N., Felekouras, E., Karavokyros, I., et al. (2018) Neutrophils to Lymphocytes Ratio as a Useful Prognosticator for Stage II Colorectal Cancer Patients. BMC Cancer, 18, Article No. 1202. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Mercier, J. and Voutsadakis, I.A. (2018) The Platelets-Neutrophils to Lymphocytes Ratio: A New Prognostic Marker in Metastatic Colorectal Cancer. Journal of Gastrointestinal Oncology, 9, 478-486. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Luo, H., Shen, K., Li, B., Li, R., Wang, Z. and Xie, Z. (2020) Clinical Significance and Diagnostic Value of Serum Nse, Cea, Ca19-9, Ca125 and Ca242 Levels in Colorectal Cancer. Oncology Letters, 20, 742-750. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Campos-da-Paz, M., Dorea, J.G., Galdino, A.S., et al. (2018) Carcinoembryonic Antigen (CEA) and Hepatic Metastasis in Colorectal Cancer: Update on Biomarker for Clinical and Biotechnological Approaches. Recent Patents on Biotechnology, 12, 269-279. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Yu, D., An, G., and Xu, L. (2016) Investigation of Efficacy Evaluation Comparison of cfDNA and CEA in Colorectal Cancer. Clinical Laboratory, 62, 1947-1953. [Google Scholar] [CrossRef]
|